Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir + lamivudine after liver transplantation with HBIG withdrawal for prevention of hepatitis B recurrence
ACTRN12611001236987Phase 4Recruiting
- Sponsor
- Professor Peter Angus
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of tenofovir, lamivudine in hepatitis B (HBV), sponsored by Professor Peter Angus. Started Sep 2010; status: recruiting.
02
Drugs
tenofovirlamivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ACTRN12611001236987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001236987.